Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Khurana, Preeti  [Clear All Filters]
2024
Ropret S, Khurana P, Fabčič T, Cvetkovska J, Trobec A, Jokhadar ŠZemljič, Ilic D, McGrath JA, Guttmann-Gruber C, Liovic M. Induced pluripotent stem cell (iPSC) line MLi005-A derived from a patient with dominant dystrophic epidermolysis bullosa (DDEB). Stem Cell Res. 2024;75:103306.
2020
Khurana P, Kolundzic N, Rogar M, Hobbs C, Wong XFColin C, Common JEA, Ilic D, Liovic M. Stem Cell Research Lab Resource: Stem Cell LineInduced pluripotent stem cell (iPSC) line MLi-003A derived from an individual with the maximum number of filaggrin (FLG) tandem repeats. Stem Cell Res. 2020;45:101827.
2019
Noli L, Khorsandi SE, Pyle A, Giritharan G, Fogarty N, Capalbo A, Devito L, Jovanovic VM, Khurana P, Rosa H, et al. Effects of Thyroid Hormone on Mitochondria and Metabolism of Human Preimplantation Embryos. Stem Cells. 2019.
Kolundzic N, Khurana P, Hobbs C, Rogar M, Ropret S, Törmä H, Ilic D, Liovic M. Induced pluripotent stem cell (iPSC) line from an epidermolysis bullosa simplex patient heterozygous for keratin 5 E475G mutation and with the Dowling Meara phenotype. Stem Cell Res. 2019;37:101424.
Kolundzic N, Khurana P, Devito L, Donne M, Hobbs C, Jeriha J, Wong XFei Colin, Common JAE, Lane EBirgitte, Dubrac S, et al. Induced pluripotent stem cell line heterozygous for p.R2447X mutation in filaggrin: KCLi002-A. Stem Cell Res. 2019;38:101462.
Kolundzic N, Khurana P, Devito L, Jeriha J, Marx J, Hobbs C, Wong XFei Colin, Common JEA, Liovic M, Dubrac S, et al. Induced pluripotent stem cell line heterozygous for p.R501X mutation in filaggrin: KCLi003-A. Stem Cell Res. 2019;39:101527.
2018
Devito L, Donne M, Kolundzic N, Khurana P, Hobbs C, Kaddour G, Dubrac S, Gruber R, Schmuth M, Mauro T, et al. Induced pluripotent stem cell line from an atopic dermatitis patient heterozygous for c.2282del4 mutation in filaggrin: KCLi001-A. Stem Cell Res. 2018;31:122-126.